Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (1071-1080 of 1,157) with videos related to

Pageof 116
Sort By:
International Journal of Environmental Research and Public Health|September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different PredictorsRaffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy|March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter StudyRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Annals of Clinical and Translational Neurology|July 6, 2024
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Annals of Clinical and Translational Neurology|July 7, 2025
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple SclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Pain and Therapy|September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 PatientsRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2023
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypesEloy Martinez-Heras, Elisabeth Solana, Francesc Vivó, et al.
Neuroimage|September 14, 2017
Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS studyAlexandra de Sitter, Martijn D Steenwijk, Aurélie Ruet, et al.
Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Therapeutic Advances in Neurological Disorders|June 9, 2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategiesPietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Pageof 116

Showing results (1071-1080 of 1,157) with videos related to

Sort By:
Pageof 116
International Journal of Environmental Research and Public Health|September 9, 2022
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different PredictorsRaffaele Ornello, Carlo Baraldi, Fayyaz Ahmed, et al.
Pain and Therapy|March 29, 2021
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter StudyRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Annals of Clinical and Translational Neurology|July 6, 2024
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Annals of Clinical and Translational Neurology|July 7, 2025
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple SclerosisPietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, et al.
Pain and Therapy|September 26, 2021
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 PatientsRaffaele Ornello, Fayyaz Ahmed, Andrea Negro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2023
Diffusion-based structural connectivity patterns of multiple sclerosis phenotypesEloy Martinez-Heras, Elisabeth Solana, Francesc Vivó, et al.
Neuroimage|September 14, 2017
Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS studyAlexandra de Sitter, Martijn D Steenwijk, Aurélie Ruet, et al.
Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Therapeutic Advances in Neurological Disorders|June 9, 2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategiesPietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
Pageof 116